Gyros AB Quality Management System Receives ISO 9001:2008 Certification
News Dec 18, 2012
Gyros AB has announced that its quality management system has received ISO 9001:2008 certification.
The certification offers further reassurance to customers using the Gyros nanoliter-scale immunoassay platform that the products and services they receive are of a consistently high standard.
The Gyros platform is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands.
The quality management system was ISO 9001:2008 certified by Svensk Certifiering Norden.
Erik Walldén, CEO at Gyros, commented: “At Gyros we have developed our Quality Management System over many years in order to establish well-functioning operating procedures for all parts of the company. Becoming ISO 9001 registered enables customers to feel even more confident in our products and services, as this is a confirmation that we follow internationally accepted standards for quality management.”
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Some Immune Cells May Help Tumors Instead of Destroying ThemNews
New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.READ MORE
Faster, More Accurate Cancer Detection Using NanoparticlesNews
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.READ MORE